Finanzen von Optimi Health Corp (OPTH)OPTHOptimi Health Corp

Evaluating the bottom line, Optimi Health Corp maintains a gross margin of -138.01%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -1363.73%, while the net margin is -1599.87%. These profitability ratios, combined with a Return on Equity (ROE) of -88.70%, provide a clear picture of how effectively OPTH converts its operational activities into shareholder value.

In the context of the broader market, OPTH competes directly with industry leaders such as BHST and OMEX. With a market capitalization of $27.43M, it holds a significant position in the sector. When comparing efficiency, OPTH's gross margin of -138.01% stands against BHST's 57.51% and OMEX's N/A. Such benchmarking helps identify whether Optimi Health Corp is trading at a premium or discount relative to its financial performance.

Optimi Health has shown significant revenue fluctuations, with a total revenue of 232,700 CAD in Q1 2025 but a net income loss that has worsened to -2,404,430 CAD in Q3 2026. The gross margin remains negative, reflecting ongoing operational challenges.